Bissig-Choisat, Beatrice
Wang, Lili
Legras, Xavier
Saha, Pradip K.
Chen, Leon
Bell, Peter
Pankowicz, Francis P.
Hill, Matthew C.
Barzi, Mercedes
Leyton, Claudia Kettlun
Leung, Hon-Chiu Eastwood
Kruse, Robert L.
Himes, Ryan W.
Goss, John A.
Wilson, James M.
Chan, Lawrence
Lagor, William R.
Bissig, Karl-Dimiter
Article History
Received: 26 February 2015
Accepted: 28 April 2015
First Online: 17 June 2015
Competing interests
: J.M.W. is an advisor to REGENXBIO, Dimension Therapeutics, Solid Gene Therapy and Alexion, and is a founder of, holds equity in and has a sponsored research agreement with REGENXBIO and Dimension Therapeutics; in addition, he is a consultant to several biopharmaceutical companies and is an inventor on patents licensed to various biopharmaceutical companies. The remaining authors declare no competing financial interests.